Increased desmin expression in hindlimb muscles of aging rats by David W. Russ & Jessica S. Grandy
ORIGINAL ARTICLE
Increased desmin expression in hindlimb muscles
of aging rats
David W. Russ & Jessica S. Grandy
Received: 7 March 2011 /Accepted: 27 June 2011 /Published online: 7 July 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Background Aging skeletal muscle frequently exhibits a
reduction in force produced per unit muscle tissue,
variously termed muscle quality, specific tension or dyna-
penia. Muscles from animals in which desmin expression is
reduced exhibit similar properties, raising the possibility
that reduced desmin expression contributes to impaired
force production in aging muscles.
Methods We examined expression of desmin and synemin,
both intermediate filament proteins, in the plantarflexor
muscles of adult (6–8 months) and older (24 months) rats.
We have previously reported age-related reductions in
muscle quality and sarcoplasmic reticulum function in
these animals.
Results Significant effects of age and muscle were found
for the expression of desmin (P=0.040 and <0.001
respectively), but not synemin. Desmin expression was
increased in the aging muscles, with the greatest changes
observed in the gastrocnemius muscles. Muscle quality, but
not muscle mass, was reduced in the aging plantarflexor
muscles.
Conclusions Loss of desmin does not account for reduced
force production in aging muscles. The potential effects of
the age-related increase in desmin on muscle function
remain unclear, but may include dissipation of contractile
force.










TBS-T Tris-buffered saline with TWEEN20
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1 Introduction
Desmin is an intermediate filament protein of ∼53-kD
molecular weight and is a major component of the
cytoskeleton of skeletal muscle [1]. Desmin is associated
with z-discs and nebulin in the thin filaments of striated
muscle sarcomeres and has connections to the sarcolem-
ma, mitochondria, and nucleus [2, 3]. Functionally,
desmin appears to be important in stabilizing sarcomeres
and maintaining cell compliance [4], and is essential for
maintaining the structural integrity of skeletal muscle [5].
Not surprisingly then, alterations in desmin have been
linked to a number of specific myopathies in humans [6–
8]. It has been suggested that desmin supports sarcomere
alignment and transmission of both active and passive
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muscle force [5, 9]. Extensive research has been
performed on transgenic mice that do not express desmin
(i.e., desmin knockout (KO) mice). Several studies have
shown that these animals produce less force when
compared to wild-type control, even when force was
normalized to muscle physiological cross-sectional area
(i.e., specific force was reduced) [10–13], although this
finding is not universal [9].
Increased age has also been associated with a
reduction in muscle force production, even when changes
in muscle size and mass have been taken into account
[14–20]. This loss of force produced per unit muscle tissue
is variously termed muscle quality, specific tension or
dynapenia [21]. Several potential mechanisms have been
put forth to account for this loss of force production,
including: selective contractile protein loss [22], modifi-
cation of contractile proteins that impairs crossbridge
binding [19] and impairments of excitation–contraction
(E–C) coupling [15, 17, 20, 23]. However, age-related
changes in cytoskeletal force transmission could also play
a role, particularly in light of the aforementioned reduc-
tions in specific force reported in desmin knockout mice.
However, there are surprisingly few studies of changes in
cytoskeletal proteins with aging, although there have been
some suggestions that cytoskeletal protein expression
might decrease with age [24].
A few studies have examined the effects of aging on
desmin. Qualitative differences in desmin staining of
cryosections from old and young muscles have been
reported in both rats [25] and humans [26]. More
recently, Piec and colleagues [27] assessed desmin in a
more systematic and quantitative manner in the gastroc-
nemius muscles of old and young rats. Interestingly, these
studies all reported either an increase or no change in
desmin with increasing age. However, none of these
studies reported any information regarding muscle force
production. Furthermore, none of these studies systemat-
ically evaluated potential age-muscle interactions with
regard to desmin expression, despite the fact that
increasing evidence indicates that many age-related
changes in muscle (e.g., oxidative enzyme activity,
calcium release, myosin isoforms, and specific tension)
are muscle specific [20, 28, 29].
We therefore chose to examine the effect of aging on
desmin expression in the four major rat plantarflexor
muscles in a subset of animals in which we had
previously found age-related reductions in muscle quality
and sarcoplasmic reticulum function. Of note, these
changes occurred in the absence of major muscle atrophy.
In addition, we determined the expression of a second
intermediate filament protein, synemin, to get a sense of
whether any age-related changes might be generalized to
intermediate filaments, or if they were specific to desmin.
We hypothesized that desmin, but not synemin, expres-
sion would be reduced with aging, consistent with data
from desmin knockout studies reporting reduced force
generation.
2 Methods
2.1 Animals and ethical approval
Animal use and all procedures were approved by the
Ohio University Institutional Animal Care and Use
Committee, and the Principles of laboratory animal
care (NIH publication No. 86–23, revised 1985), were
followed throughout the study. Data from total of six
adult (6–8 months) and six older (24 months), male
F344/BN hybrid rats, representing a subset of animals
used in a previous study, are presented here. The aging
animals used here were at an age of ∼90% survival rate
[30], but have been shown to exhibit marked declines in
both muscle quality [20] and locomotor function [31].
Animals were housed in an environmentally controlled
facility (12–12-h light–dark cycle, 22°C), and had ad
libitum access to food and water. These animals represent
a subset from a previously published study [20] that
evaluated age-related changes in muscle quality and
sarcoplasmic reticulum function. For purposes of this
brief report, we focus on the immunoblotting experi-
ments related to intermediate filament proteins; however,
we also present the contractile data from the subset of
previously studied animals
2.2 Muscle contractile testing
Animals were anesthetized with an intraperitoneal injection
of a ketamine/xylazine (40:10 mg kg−1 body mass,
respectively). The plantarflexor muscle group was dissected
free and clamped via the Achilles tendon in series with a
force transducer, as previously described [20]. Pulses
(200 μs) from a Grass S48 stimulator (Astro-Med) were
delivered via a hook electrode (Harvard Apparatus) to the
sciatic nerve at supra-maximal (125% voltage needed to
produce maximum twitch force) intensity. Muscles were
potentiated with ten 100-ms, 100-Hz trains (one train per
10 s) [32], followed by administration of 500-ms trains of
1, 5, 10, 30, 50, 75, 100, and 125 Hz (also one train per
10 s) to determine the force frequency relationship. Two
trains of each frequency were delivered in each trial, with
the order randomly determined for each animal. Following
testing, the plantarflexor muscles (soleus, plantaris, and
medial and lateral gastrocnemii) were dissected free of
surrounding tissues, blotted dry, and weighed. Animals
were sacrificed following tissue collection by an intracar-
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dial injection of anesthesia (euthasol, 100 mg kg−1). Muscle
quality was determined by dividing plantarflexor force by
sum of the masses of the four plantarflexor muscles, as has
been performed previously [33–35].
2.3 Tissue processing
After weighing, each of the four plantarflexor muscles was
dissected and was divided into two portions. The first
portion was frozen in liquid N2 and stored at −80°C for
later immunoblotting experiments. The second was homog-
enized (PRO 200, Oxford, CT, USA) fresh on ice for SR
Ca2+ uptake and release assays presented elsewhere [20].
Frozen muscle samples were brought to 4°C, weighed,
minced on cold glass, homogenized in buffer (10 mM
sodium phosphate, pH 7.2, 2 mM EDTA, 10 mM sodium
azide, 120 mM sodium chloride, 2% NP-40, plus HALT
(Pierce) protease inhibitor), incubated on ice for 1 h, and
centrifuged at 14,000×g for 30 min. Pellets were resus-
pended in 200 μL of buffer (150 mM postassium chloride,
20 mM Tris, pH 7.0). Both pellet and supernatant fractions
were saved. Total protein concentrations were estimated
using a Modified Bradford Assay (Pierce) for both
fractions.
2.4 SDS-PAGE and Western blotting
Samples were diluted 1:1 with 2× Laemmli sample buffer
and 30-μg protein were separated via sodium dodecylsul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) on
7.5% gels with 5% stacking gels, at 125 V. Preliminary
testing found no desmin or synemin in the supernatant
fraction. Therefore, only the results of the pellet analyses
are presented here.
Following SDS-PAGE, proteins were transferred to
PVDF for 2 h at 4°C in transfer buffer (15% methanol,
25 mM Tris, and 192 mM glycine). Once transfer was
complete, membranes were blocked at room temperature
for 1 h in blocking buffer (SuperBlock, Thermo Scien-
tific, IL), then incubated with primary antibodies over-
night at 4°C. Primary antibodies for both desmin (Cell
Signaling Technologies) and synemin (Sigma) were
diluted 1:2,000 in blocking buffer. After primary incuba-
tion, membranes were washed 5×5 min in Tris-buffered
saline+Tween20 (TBS-T) and incubated for 1 h at room
temperature in secondary antibody (Goat anti-Rabbit, Li-
Cor) which was diluted in blocking buffer (1:10,000).
Following secondary incubation, membranes were once
again washed 5×5 min in TBS-T, then rinsed for 5 min
with TBS. Membranes were dried in the dark overnight
prior to scanning with the LiCor Odyssey system. The
membranes were scanned via the LiCor Odyssey system
for densitometric band analysis. After scanning, the
membranes were stained with Coomassie Brilliant Blue
R250 and within blot band intensities were normalized to
total protein per lane determined from the stained,
scanned membrane. The blots were all performed in
duplicate. A known amount of rabbit IgG was run on
each gel and used as a standard for normalization of
bands from different blots.
2.5 Statistical analyses
Animal and muscle masses were compared using unpaired t
tests. Muscle quality was analyzed using two-way (age×
frequency) repeated measures analysis of variance
(ANOVA), with frequency as the repeated factor. In the
event of a significant age×frequency interaction, post hoc
tests were performed using unpaired t tests. Desmin and
synemin expression were analyzed with mixed-models two-
way (age×muscle) ANOVAs with muscle as a repeated
factor. Because we were primarily interested in age differ-
ences within a given muscle, we planned a priori to
compare old and young animals within using unpaired t
tests, in the event a significant effect of age was found. All
data are presented as means±SE, and all statistic analyses
were performed using SPSS, with the threshold for
significance set at P≤0.05.
3 Results
3.1 Immunoblotting
Desmin expression was greatest in the soleus muscle,
regardless of age (P=0.001) and age was associated with
an overall increase in desmin expression (P=0.040), but
there was no age×muscle interaction (P=0.461). Within-
muscle, age-related differences were significant in both the
medial and lateral gastrocnemius muscles (P=0.048 and
0.018, respectively), but not the soleus or plantaris
(Fig. 1a). In contrast, no significant main effects or
interactions for muscle and age were observed for synemin
expression (Fig. 1b).
3.2 Muscle quality
Muscle quality, determined by dividing plantarflexor
group force by total plantarflexor muscle mass, was
similar in adult and aging muscles at low stimulation
frequencies. At higher frequencies (≥75 Hz) however, the
adult muscles exhibited higher muscle quality than the
older muscles (Table 1). Consistent with these findings,
there was a significant age×frequency interaction (P=
0.021), though the main effect of age did not reach
significance (P=0.074).
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3.3 Animal and muscle mass
The older rats were significantly heavier than the adult ones.
Overall, there was no significant difference in total plantar-
flexor muscle mass. Among the individual muscles, only the
medial gastrocnemius exhibited any age-related decline in
musclemass, and the soleus muscles of the older animals were
actually heavier than those of the adult animals (Table 1).
4 Discussion
The major finding of this study was that, contrary to our
hypothesis, desmin expression increased with increasing
age. Synemin expression was unchanged with age, suggest-
ing that an overall increase in intermediate filament proteins
was not occurring with age. Despite the increase in desmin,
plantarflexor muscle quality was lower in the older animals,
in contrast to what we expected based on the results of
previous studies of desmin knockout mice.
The increased desmin expression in the gastrocnemius
muscles is similar to the data of Piec and colleagues [27],
and extends these findings to the other major plantarflexors.
Though less robust (i.e., not statistically significant), a trend
for increased desmin expression with aging was also
observed in the soleus and plantaris muscles, suggesting
that this increase may not exhibit the muscle specificity
associated with other age-related changes [28, 29, 36].
Consistent with others, we found that desmin expression
was greater in the soleus muscle than the other hindlimb
muscles (plantaris and gastrocnemii), which are known to
contain greater amounts of type II myosin heavy chain
isoforms [10, 37]. As aging is often associated with an
increase in the muscular type I myosin heavy chain profile,
it is possible that the age-related increase we observed was
a function of fiber type transitions. However, our previously
published data on these animals indicate that only minor
changes in overall myosin isoform composition occurred
[20], making it unlikely to account for the increased desmin
expression.
The increase in desmin was not accompanied by an
increase in synemin, another intermediate filament protein
that has been shown to co-localize with desmin in
intermediate filaments. While our methods were not
sufficiently quantitative to determine exact molar ratios of
synemin to desmin, as has been done elsewhere [38], our
results suggest that the synemin:desmin ratio should
decrease with age. It has been shown that increases in the
Fig. 1 a Top, mean (+SE)
desmin expression in hindlimb
muscles of adult (A) and older
(O) rats (N=6/group). Bottom,
representative immunoblot for
desmin. b Top, mean (+SE)
synemin expression in hindlimb





between adult and aging rats
Table 1 Animal and Muscle Masses
Adult mean (SE) Old mean (SE) P value
Body mass (g) 409 (21) 586 (6) <0.001
Muscle mass (mg)
Soleus 171 (10) 197 (12) 0.049
Plantaris 423 (22) 443 (15) 0.474
M. gastrocnemius 1094 (54) 919 (29) 0.017
L. gastrocnemius 1,049 (98) 1,088 (28) 0.717
Muscle quality (N/g)
1 Hz 2.033 (0.152) 1.829 (0.168) 0.389
5 Hz 2.140 (0.175) 1.861 (0.164) 0.271
10 Hz 2.225 (0.185) 2.088 (0.134) 0.562
25 Hz 4.408 (0.555) 3.598 (0.241) 0.210
50 Hz 6.506 (0.522) 5.490 (0.574) 0.220
75 Hz 7.819 (0.379) 6.332 (0.502) 0.039
100 Hz 8.169 (0.413) 6.444 (0.555) 0.032
125 Hz 8.098 (0.404) 6.423 (0.634) 0.050
178 J Cachexia Sarcopenia Muscle (2011) 2:175–180
synemin:desmin ratio are associated with problems in
correct assembly of intermediate filaments. However, the
effects of a decrease in the ratio have not been reported, to
our knowledge. It has been reported that synemin persists in
the myotendinous and neuromuscular junctions, but is
absent from the z-discs of desmin KO mice [39]. Though
highly speculative, this may indicate that the increased
desmin we observed in the older muscles here is not
associated with the z-disc. Such a finding would be
consistent with the report of Ansved who found that the
pattern of desmin, but not spectrin, staining was altered
with age [25]. These investigators suggested that the altered
pattern of desmin staining in old muscles is associated with
increased deposition of desmin in intermyofibrillar spaces
that were increased with age, due to loss of myofibrils [25].
Increased cytoplasmic desmin expression was observed in
muscles subjected to a denervation–reinnervation protocol
[40]. It is widely accepted that aging is associated with a
denervation–reinnervation process, and this may account
for our observation of increased desmin. One possible
method of addressing the issue of the localization of the
increased desmin with aging in future studies would be to
label longitudinal sections from old and young animals,
fixed at various sarcomere lengths as described by Bowman
and colleagues to study obscurin [41].
As reported previously [20], rats of this strain and age
differential exhibited reduced plantarflexor force produc-
tion, but minimal age-related muscle atrophy, resulting in
reduced muscle quality. Clearly, reduced desmin expression
was not the cause. However, one previous study [9] has
reported increased specific force in muscles from desmin
KO mice. These investigators posit that desmin acts a
“viscous element that dissipates mechanical energy.” If this
is the case, then an age-associated increase in desmin could
indeed have contributed to impaired muscle quality we
observed in the aging rats. Given the number of other
studies reporting reduced specific force with aging however,
this remains an unsettled issue.
Another group has suggested that desmin is necessary
for optimal E–C coupling [13]. Our previous study found
that aging was associated with impaired sarcoplasmic
reticulum calcium release (a key step in E–C coupling).
Thus, it is tempting to speculate that the increase in desmin
represents a failed, or only partially successful, compensa-
tion in the aging muscles. However, Wieneke and col-
leagues suggested that desmin's role in the excitation–
contraction coupling process occurred upstream of the
calcium release channel, and was possibly related to
maintaining t-tubule integrity and function. In contrast, we
observed impaired calcium release from sarcoplasmic
reticulum vesicles, a process that was independent of t-
tubule function and action potential propagation, thus it
seems unlikely that the two processes are related.
The potential role of changes in desmin expression in
age-related alterations in muscle function remains un-
clear. Our results confirm and extend previous findings
of an age-related increase in expression of desmin in
skeletal muscle. One study suggests that increased
desmin could directly contribute to impaired muscle
quality through mechanical blunting of force production.
This is consistent with our results, but clearly the issue
remains equivocal. It is difficult to study normal aging in
desmin knockout animals, due to their shortened lifespan
[42]. However future studies may be able to address this
issue in aging animals by using advanced molecular
biology techniques (e.g., RNAi knockdown).
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